Search results for "Guidelines"

showing 10 items of 617 documents

Spanish Society of Hypertension position statement on the 2017 ACC/AHA hypertension guidelines

2018

The American College of Cardiology (ACC) and the American Heart Association (AHA) have recently published their guidelines for the prevention, detection, evaluation, and management of hypertension in adults. The most controversial issue is the classification threshold at 130/80 mmHg, which will allow a large number of patients to be diagnosed as hypertensive who were previously considered normotensive. Blood pressure (BP) is considered normal (<120 mmHg systolic and <80 mmHg diastolic), elevated (120-129 and <80 mmHg), stage 1 (130-139 or 80-89 mmHg), and stage 2 (≥140 or ≥90 mmHg). Out-of-office BP measurements are recommended to confirm the diagnosis of hypertension and for titra…

Hipotensió arterialCorazónMedicinaMalalties cardiovascularsEnfermedad cardiovascularGuidelines030204 cardiovascular system & hematologyCardiovascular diseaseCardiovascular riskPressió sanguíniaPresión sanguínea03 medical and health sciencesCardiovascular diseases0302 clinical medicineHypertensionHipertensiónBlood pressureInternal Medicine030212 general & internal medicineHypotensionCardiology and Cardiovascular MedicineSistema cardiovascular
researchProduct

Bone marrow biopsy in Hodgkin's lymphoma.

2004

In the study of patients with Hodgkin's lymphoma (HL) the evaluation of bone marrow biopsy (BMB) can be difficult. In this review we analyze the main diagnostic features and the clinical risk factors of BM involvement. Although the role of BMB is criticized by some authors, its value is irreplaceable in the staging of HL and in the diagnosis of primary medullary HL. The Ann Arbor staging committee criteria should be revised and updated in the light of the current immunohistochemical studies that give a fundamental help in the diagnostic process. A single BMB should be adequate for diagnosis in most instances. In cases of suspicious involvement a controlateral BMB could be performed.

Hodgkin's lymphoma.Diagnosis DifferentialPractice Guidelines as TopicHumansBone marrowbiopsyBone Marrow ExaminationHodgkin DiseaseImmunophenotypingEuropean journal of haematology
researchProduct

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper fr…

2014

Item does not contain fulltext AIMS: Homozygous familial hypercholesterolaemia (HoFH) is a rare life-threatening condition characterized by markedly elevated circulating levels of low-density lipoprotein cholesterol (LDL-C) and accelerated, premature atherosclerotic cardiovascular disease (ACVD). Given recent insights into the heterogeneity of genetic defects and clinical phenotype of HoFH, and the availability of new therapeutic options, this Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society (EAS) critically reviewed available data with the aim of providing clinical guidance for the recognition and management of HoFH. METHODS AND RESULTS: Early diagn…

Homozygous Familial HypercholesterolemiaSettore MED/09 - Medicina InternaVascular damage Radboud Institute for Health Sciences [Radboudumc 16]MipomersenLipoprotein apheresisGene FrequencyDiagnosisconsensuMedicineChildPhenotypic heterogeneityCiències de la salutAnticholesteremic AgentsHomozygoteCiencias de la saludPedigree3. Good healthEuropePhenotypeCardiovascular DiseasesPractice Guidelines as TopicBlood Component Removallipids (amino acids peptides and proteins)HipercolesterolèmiaHIPERCOLESTEROLEMIA (DIAGNÓSTICO)Cardiology and Cardiovascular MedicineLipoprotein apheresismedicine.medical_specialtyConsensusClinical UpdateEvinacumabReviewsguide line1102 Cardiovascular Medicine And Haematology1016-5169Diagnosis DifferentialHyperlipoproteinemia Type IIGenetic HeterogeneityArcus SenilisHomozygous familial hypercholesterolaemiaGeneticsXanthomatosisHumansGynecologybusiness.industryStatinsHealth sciencesCholesterol LDLAtherosclerosisEzetimibeLomitapideLiver TransplantationEarly DiagnosisCardiovascular System & HematologyHomozygous familial hypercholesterolaemia; consensus; guide lineMutationEuropean atherosclerosis societybusinessAterosclerosiEuropean Heart Journal
researchProduct

Dyslipidemia management with medical nutrition therapy: current status and perspectives

2013

In Italy, patients with dyslipidennia account for 15-20% of the adult population with major healthcare and socio-economic impact. According to the ESC/EAS guidelines for the management of dyslipidemias, desirable cholesterol and triglyceride levels can be achieved with a synergy between drug treatment and adequate diet therapy. However, what diets should be adopted? In this review article, different types of dietary treatments are compared, with a special focus on diet education. The new scientific frontier of nutrigenetics is also discussed.

IncidenceCholesterol HDLCholesterol LDLDiet dyslipidemia metabolic syndrome nutrition obesityDiet MediterraneanDietDiet Carbohydrate-RestrictedNutrigenomicsItalyPatient Education as TopicPractice Guidelines as TopicHumansNutrition TherapyDiet Fat-RestrictedLife StyleBiomarkersTriglyceridesDyslipidemias
researchProduct

Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer

2021

Patients with childhood, adolescent, and young adult cancer who will be treated with gonadotoxic therapies are at increased risk for infertility. Many patients and their families desire biological children but effective communication about treatment-related infertility risk and procedures for fertility preservation does not always happen. The PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group reviewed the literature and developed a clinical practice guideline that provides recommendations for ongoing communication methods for fertility preservation for patients who were diagnosed with childhood, adolescent, and young adult cancer at a…

InfertilityAdultMalemedicine.medical_specialtyAdolescentfertility preservationmedia_common.quotation_subjectMEDLINEMedizinFertilityGuidelines as Topic03 medical and health sciences0302 clinical medicineCancer SurvivorsSDG 3 - Good Health and Well-beingNeoplasmsMedicineHumansgonadotoxic therapiesFertility preservationYoung adultGrading (education)Childmedia_commonchildhoodCancer030219 obstetrics & reproductive medicinebusiness.industryCancerGuidelinemedicine.diseaseOncology030220 oncology & carcinogenesisFamily medicineDisease Progressionyoung adultFemalebusinessinfertilityreproductive medicineThe Lancet Oncology
researchProduct

[Fertility preservation in the oncology patient].

2017

In recent years, medical advances have substantially improved survival of cancer patients, generating growing concern about the quality of life of the survivors. Increased attention has been paid to reproductive problems after oncological treatments. International guidelines on fertility preservation in cancer patients require that healthcare teams discuss, as early as possible, the impact of cancer treatments on fertility and encourage access to fertility preservation techniques. The development of these techniques in women is a recent effort and many patients and health care providers are not familiar with their rapid expansion. This article discusses indications, results, and risks of th…

Infertilitymedicine.medical_specialtyInternationalitymedia_common.quotation_subjectlcsh:MedicineImproved survivalFertility03 medical and health sciences0302 clinical medicineCancer SurvivorsNeoplasmsHealth caremedicineHumansFertility preservationIntensive care medicinemedia_commonlcsh:R5-920030219 obstetrics & reproductive medicinebusiness.industryRapid expansionlcsh:RCancerFertility PreservationGeneral Medicinemedicine.diseasefemaleFertility030220 oncology & carcinogenesisPractice Guidelines as TopicQuality of Lifeinfertilitylcsh:Medicine (General)businessMedwave
researchProduct

A systematic analysis of duplicate records in Scopus

2015

In recent years, the Web of Science Core Collection and Scopus databases have become primary sources for conducting studies that evaluate scientific investigations. Such studies require that duplicate records be excluded to avoid errors of overrepresentation. In this line, we identify duplicate records in Scopus and examine their origins. Identifying journals with duplicate records in Scopus, selecting and downloading bibliographic journal records, and identifying and analyzing the duplicate records is the methodology adopted. Duplicate records are found when articles published in a journal are incorrectly mapped by Scopus to this journal and to a different journal from the same publisher a…

Information retrievalComputer scienceMEDLINEScopusLibrary and Information SciencesComputer Science ApplicationsBibliographic recordDuplicate recordsIndexing errorsScopus databaseBibliographic control guidelinesGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)Bibliometric indicators overdimensionalized
researchProduct

Adaptación transcultural al español y validez de contenido de 3 escalas de riesgo nutricional

2022

Introduction: There are various scales designed to determine the risk of malnutrition at hospital admission in children. However, most of these instruments are developed and published in English. Their cross-cultural adaptation and validation being mandatory in order to be used in our country. Objectives: Cross-culturally adapt three scales designed to determine the risk of malnutrition linked to the disease and determine the validity of their content. Material and methods: Cross-cultural adaptation using the translation-back-translation met-hod in accordance with the recommendations of the International Test Commission Guidelines for Translating and Adapting Tests. Content validity was mea…

Inpatient childAdverse effectsMalnutritionPediatrics Perinatology and Child HealthUndernutritionScreening toolCross-cultural comparisonAdaptationGuidelinesResults reproducibilityRisk assessmentAnales de Pediatría
researchProduct

European expert opinion on the management of invasive candidiasis in adults

2011

Item does not contain fulltext This report discusses the present status of antifungal therapy and treatment options for candidaemia, considered by experts in the field in Europe. A conference of 26 experts from 13 European countries was held to discuss strategies for the treatment and prevention of invasive candidiasis, with the aim of providing a review on optimal management strategies. Published and unpublished comparative trials on antifungal therapy were analysed and discussed. Commonly asked questions about the management of candidaemia were selected, and possible responses to these questions were discussed. Panellists were then asked to respond to each question by using a touchpad ans…

Invasive mycoses and compromised host Translational research [N4i 2]AdultMicrobiology (medical)medicine.medical_specialtyAntifungal Agentsmedicine.medical_treatmentPlacebo-controlled studyMEDLINEInvasive mycoses and compromised host Infection and autoimmunity [N4i 2]MicrobiologyMedicineHumanscandidaemiaCandidiasis InvasiveguidelinesIntensive care medicineWatchful Waitingtherapybusiness.industryTreatment optionsPathogenesis and modulation of inflammation Infection and autoimmunity [N4i 1]General MedicineInvasive candidiasisComparative trialAntibiotic Prophylaxismedicine.diseaseOptimal managementEuropeIntensive Care UnitsInfectious DiseasesconsensusExpert opinioncandidabusinessWatchful waitingClinical Microbiology and Infection
researchProduct

What is new for an old molecule? : Systematic review and recommendations on the use of resveratrol

2011

BackgroundResveratrol is a natural compound suggested to have beneficial health effects. However, people are consuming resveratrol for this reason without having the adequate scientific evidence for its effects in humans. Therefore, scientific valid recommendations concerning the human intake of resveratrol based on available published scientific data are necessary. Such recommendations were formulated after the Resveratrol 2010 conference, held in September 2010 in Helsingør, Denmark.MethodologyLiterature search in databases as PUBMED and ISI Web of Science in combination with manual search was used to answer the following five questions: (1)Can resveratrol be recommended in the prevention…

Isi web of sciencePhytochemistrymedicine.medical_specialtySystematic ReviewsNon-Clinical Medicineendocrine system diseasesClinical Research DesignScience PolicyPhytopharmacologyScienceMEDLINEPharmacologyResveratrolCardiovascularScientific evidenceAnimal datachemistry.chemical_compoundEndocrinologyComplementary and Alternative MedicineStilbenesmedicineHumansObesityIntensive care medicineNutritionDiabetic EndocrinologyTreatment GuidelinesHealth Care PolicyMultidisciplinaryCancer preventionbusiness.industryorganic chemicalsQRfood and beveragesResearch AssessmentCoronary heart diseaseClinical trialChemistryOncologychemistryResveratrolMedicinePublic HealthPreventive MedicinebusinessCancer Preventionhormones hormone substitutes and hormone antagonistsResearch Article
researchProduct